Standout Papers

Drotrecogin Alfa (Activat... 2012 2026 2016 2021 2012 250 500 750

Immediate Impact

3 from Science/Nature 76 hit
Sub-graph 1 of 19

Citing Papers

Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes
2024 Hit
Sepsis and Septic Shock
2024 Hit
6 intermediate papers

Works of Burkhard Vangerow being referenced

Safety and Pharmacokinetics of CXCR4 Peptide Antagonist, LY2510924, in Combination with Durvalumab in Advanced Refractory Solid Tumors
2020
Drotrecogin Alfa (Activated) in Adults with Septic Shock
2012 Hit

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Burkhard Vangerow 625 263 257 245 155 14 1.1k
Steven P. LaRosa 792 1.3× 282 1.1× 333 1.3× 116 0.5× 148 1.0× 31 1.2k
Anthony Dal Nogare 607 1.0× 285 1.1× 377 1.5× 203 0.8× 459 3.0× 7 1.4k
Pierre Singer 690 1.1× 277 1.1× 137 0.5× 186 0.8× 150 1.0× 14 1.0k
A Kübler 686 1.1× 281 1.1× 163 0.6× 166 0.7× 161 1.0× 10 1.1k
F. Schindel 716 1.1× 294 1.1× 158 0.6× 170 0.7× 135 0.9× 13 1.2k
István Pénzes 708 1.1× 287 1.1× 160 0.6× 160 0.7× 218 1.4× 22 1.2k
Peder Carl 732 1.2× 428 1.6× 140 0.5× 262 1.1× 216 1.4× 15 1.3k
Juan C. Mira 636 1.0× 405 1.5× 364 1.4× 144 0.6× 249 1.6× 26 1.3k
Roger C. Bone 410 0.7× 157 0.6× 360 1.4× 152 0.6× 175 1.1× 8 1.1k
Pierre Perez 705 1.1× 289 1.1× 246 1.0× 305 1.2× 336 2.2× 32 1.5k

All Works

Loading papers...

Rankless by CCL
2026